July 11th Options Now Available For Regeneron Pharmaceuticals (REGN)

Analysis of Regeneron Pharmaceuticals (REGN) options reveals potential yield-boosting strategies for investors. Selling a $590 put offers a 4.54% return (38.56% annualized) if it expires worthless, with a 55% probability based on current data. A covered call strategy at the $610 strike yields 6.96% if the stock is called away, and a 4.61% boost (39.17% annualized) if it expires worthless, with a 53% probability. The implied volatility for the put and call contracts are 41% and 47% respectively, while the actual trailing twelve month volatility is 33%.

Analysis

Analysis of Regeneron Pharmaceuticals (REGN), trading at $596.00 per share, reveals two options strategies offering potential yield enhancement. Selling the $590 strike put contract, with a current bid of $26.80, could allow an investor to acquire shares at an effective cost basis of $563.20, a discount to the current price, or achieve a 4.54% return (38.56% annualized) if the put expires worthless, an outcome with an estimated 55% probability. Alternatively, a covered call strategy involving selling the $610 strike call option for a $27.50 premium (against shares purchased at $596.00) could yield a total return of 6.96% if the stock is called away by the July 11th expiration, or provide a 4.61% income boost (39.17% annualized) if the call expires worthless, with a 53% probability of such an occurrence. Notably, the implied volatilities for the put (41%) and call (47%) contracts are considerably higher than REGN's actual trailing twelve-month historical volatility of 33%, suggesting that option premiums are currently rich, potentially favoring option sellers.

Key Decisions for Investors

• Investors interested in acquiring Regeneron Pharmaceuticals (REGN) at a lower effective price than $596.00 could consider selling the $590 strike puts, targeting an entry point of $563.20 or a 4.54% premium return if the options expire unassigned.
• Current REGN shareholders, or those initiating a long position, might evaluate selling the $610 strike covered calls to generate income, potentially realizing a 6.96% total return if called away by July 11th, or a 4.61% yield boost if the calls expire worthless, thereby capitalizing on the elevated implied volatility.
• The spread between REGN's implied option volatility (41-47%) and its historical stock volatility (33%) indicates that option selling strategies could offer attractive risk-reward profiles; however, investors should integrate this with a thorough assessment of REGN's fundamental outlook before execution.